Gouri

Dexlevo Inc. is a South Korean medical aesthetics company founded in 2013, specializing in biopolymer technology. Dexlevo holds its own patented technology called CESABP (Collagen Enabled Solubilized Active and Biodegradable Polymer). Using this, they have developed a fully solubilized, biocompatible, and biodegradable PCL (polycaprolactone) that efficiently spreads within the skin and stimulates collagen synthesis across the entire skin surface. As a result, it improves skin thickness, density, and elasticity without forming lumps, making it a truly innovative solution for combating fundamental aging. Dexlevo has applied this technology to develop the next-generation collagen stimulator, Gouri. This is the first fully liquid PCL injection that rejuvenates the skin by enhancing collagen synthesis in the face while spreading naturally across the entire facial area. Gouri is based on the unique CESABP technology, which activates the skin’s natural collagen regeneration without the use of microparticles and offers longer-lasting cosmetic performance compared to hyaluronic acid. The key benefits of Gouri include comprehensive facial rejuvenation and enhanced collagen synthesis.